Patent · US Active

High capacity non-viral vectors

US8202544B2 · kind B2 · utility

1Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2009
Grant dateJun 19, 2012
Priority date
Expiry dateNov 19, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Non-viral vectors for delivering agents to a site within the body of an animal comprise a biocompatible nanoparticle conjugated to an avidin/biotin complex and a water soluble linear polymer comprising multiple binding sites. The agents to be delivered are conjugated to each of the multiple binding sites, thereby increasing the loading capacity of the system. Where the agents comprise siRNA, each biotin/avidin complex may carry greater than four siRNA. The biocompatible nanoparticle may also comprise a fluorescent dye for in vivo imaging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.